Stephannie Cloninger-Hultz
Family · Glen Carbon, ILNPI 1265063192
Payments from drug & device makers
Across 317 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$701
- Amgen$411
- Novo Nordisk$294
- Corcept Therapeutics$248
- Abbott$235
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,428 |
| Lilly USA, LLC | 40 | $701 |
| Amgen | 22 | $411 |
| Novo Nordisk | 21 | $294 |
| Corcept Therapeutics | 11 | $248 |
| Abbott | 14 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $197 |
| Insulet Corporation | 6 | $161 |
| Merck | 8 | $144 |
| AstraZeneca | 9 | $130 |
| Amarin Pharma, Inc. | 9 | $124 |
| Xeris Pharmaceuticals, Inc. | 3 | $84 |
| Medtronic | 4 | $83 |
| Organon | 7 | $78 |
| Nestle Healthcare Nutrition Inc. | 4 | $77 |
| Novartis | 5 | $68 |
| Boehringer Ingelheim | 4 | $65 |
| Astellas Pharma US Inc | 4 | $60 |
| Lundbeck LLC | 3 | $57 |
| Sumitomo Pharma America, Inc. | 4 | $54 |
| Agile Therapeutics, Inc. | 3 | $52 |
| Biogen | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Bayer | 3 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Johnson & Johnson | 2 | $40 |
| Exact Sciences | 2 | $34 |
| Almatica Pharma LLC | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Tandem Diabetes Care, Inc. | 2 | $28 |
| Mayne Pharma Commercial LLC | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$5,274 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 249 | $259,013 |
| MounjaroTirzepatide | 214 | $244,426 |
| TrulicityDulaglutide | 175 | $206,628 |
| JanuviaSitagliptin Phosphate | 151 | $86,772 |
| JardianceEmpagliflozin | 105 | $84,057 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 77 | $65,104 |
| FarxigaDapagliflozin Propanediol | 87 | $65,048 |
| ZenpepLipase/Protease/Amylase | 35 | $53,150 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 38 | $49,979 |
| EliquisApixaban | 94 | $32,431 |
| GemtesaVibegron | 92 | $30,684 |
| WegovySemaglutide | 20 | $28,018 |
| LinzessLinaclotide | 33 | $22,823 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $17,857 |
| KerendiaFinerenone | 24 | $16,415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $701 | $457,588424 claims |
| Novo NordiskOzempic, Wegovy, Novolog | $294 | $293,702295 claims |
| MerckJanuvia | $144 | $86,772151 claims |
| Boehringer IngelheimJardiance | $65 | $84,057105 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $130 | $73,45499 claims |
| Aimmune Therapeutics, Inc.Zenpep | $18 | $53,15035 claims |
| AbbVieLinzess, Vraylar | $1,428 | $35,07653 claims |
| PfizerEliquis | $14 | $32,43194 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $54 | $30,68492 claims |
| Johnson & JohnsonXarelto, Invokana | $40 | $20,68864 claims |
| BayerKerendia | $45 | $16,41524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Glen Carbon
- Ashley NoethGlen Carbon$271K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.